SEP 16, 2020 11:00 AM | SEPT 17, 11:00 AM SGT | SEPT 17, 4:00 PM CEST

How to Limit Patient Harm from Erroneous Results, QC Strategies Based on Risk Management

C.E. Credits: P.A.C.E. CE Florida CE
  • Scientific Fellow, Bio-Rad Laboratories

      Mr. Yundt-Pacheco performs research in quality control and patient risk issues in the Informatics Discovery Group at Bio-Rad. John has had the opportunity to work with laboratories around the world, developing practical real time, inter-laboratory quality control and proficiency testing systems. As an innovator, has developed numerous ideas leading to 37 laboratory related invention patents around the globe.

      John holds a Master’s degree in Computer Science from University of Texas at Dallas with a focus on Intelligent Systems and has a Post Master’s Certificate in Sequence Analysis and Genomics, and is a degree candidate for a Master’s degree in Biotechnology at Johns Hopkins University. In addition to authoring articles and papers on QC design, he is a popular speaker on laboratory QC and QA topics at international conferences.


    Quality Control design has for many years been focused around instrument performance. But with the new risk management approaches emerging the focus is now moving to the risk of erroneous results for patients. This presentation will describe this new approach designed to prevent patient harm from erroneous results to acceptable levels.

    Learning Objectives:
    1. Identify the steps in patient risk managed QC strategy design.
    2. Explain how to set the Severity of Harm category for an analyte.
    3. Describe 2 components of the QC design that can be changed to minimize patient risk.

    Show Resources
    Show Resources
    • See more